Natco-Lupin get USFDA’s nod for Eribulin Mesylate injection
· thehindubusinessline.com
Natco and Lupin receive USFDA approval for Eribulin Mesylate Injection, a treatment for metastatic breast cancer.
Pharma major Lupin and its alliance partner Natco Pharma have Natco) received an approval from the United States Food and Drug Administration (U.S. FDA) for Nat...